Home >> News >> Business >> Hepatitis B Vaccines Market Is Expected To Reach US$ 1.89 Bn In Terms Of Value By 2025

Hepatitis B Vaccines Market Is Expected To Reach US$ 1.89 Bn In Terms Of Value By 2025

According to the latest market report published by Credence Research, Inc. “Hepatitis B Vaccines Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global hepatitis B vaccines market was valued at US$ 1.39 Bn in 2016, and is expected to reach US$ 1.89 Bn by 2025, expanding at a CAGR of 3.5% from 2017 to 2025.

The purpose of the report is to illustrate the state of the market of Hepatitis B Vaccines, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.

Browse here for full report: https://www.credenceresearch.com/report/hepatitis-b-vaccine-market

Market Insights

Hepatitis B is life threatening liver infection. Hepatitis B vaccines market is rapidly growing as it is effective in prevention of infection than any other treatment options. Some factors such as increased awareness of hepatitis B infection prevention, government initiatives in conduction of routine immunization program are contributing the market growth of hepatitis B vaccines globally. For the purpose of study, global hepatitis B vaccines market is segmented on the basis of type of vaccines composition such as mono and combination vaccines. It is observed that in the base year 2016, combination vaccines held largest market share due to factors such as more patient compliance, better disease control and lower chances of missing immunization are driving the growth of combination vaccines market globally. On the basis of end users age, the hepatitis B vaccines market is categorized into pediatric and adult hepatitis B vaccines. Currently, adult hepatitis B vaccines is the major revenue contributing segment as adults are at a high risk of developing hepatitis B infections due to renal disease and HIV infection which is influencing the market growth of adult hepatitis B vaccines globally. Hepatitis B vaccines market is currently dominated by North America due to factors such as extensive R&D activities, higher cost of vaccines and immunization program that are driving the market growth in North America. Asia Pacific is anticipated to show highest CAGR during forecast period due to increasing healthcare awareness and government initiatives in immunization program.

Market Competition Assessment:

The hepatitis B vaccines market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Beijing Minhai Biotechnology, CSL Ltd, Dynavax Technologies, Emergent Biosolutions, GlaxoSmithKline Biologicals, Merck & Co, Inc, Novartis AG, Pfizer Inc., Sanofi  Pasteur, Serum Institute of India, Sinovac Biotech and other.

Why was the report written?

This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Hepatitis B Vaccines buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Hepatitis B Vaccines contains:

Analysis and forecast of Hepatitis B Vaccines market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Hepatitis B Vaccines market;

Assessment and forecast of Hepatitis B Vaccines market development;

Financial and business profiles of the leading companies in the Hepatitis B Vaccines industry.

Scope

– Up to date working Hepatitis B Vaccines data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Hepatitis B Vaccines for the period 2018 to 2026

– Planned Hepatitis B Vaccines additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Hepatitis B Vaccines projects by region, key countries, and companies

– Details of major planned Hepatitis B Vaccines projects in the world up to 2026

Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58438

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429

SAN JOSE

CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *